MSF's Leena Menghaney explains that the Trans-Pacific Partnership trade agreement would limit access to medicine by preventing the manufacture of affordable generic drugs.
Search results
-
Who we are
- Principles
- How we work
- History
- Accountability & reporting
- US office
- Offices around the world
-
Books about MSF
- An Imperfect Offering: Humanitarian Action for the Twenty-First Century
- Because Tomorrow Needs Her
- Doctors Without Borders: Humanitarian Quests, Impossible Dreams of Médecins Sans Frontières
- In the Eyes of Others: How People in Crises Perceive Humanitarian Aid
- Humanitarian Negotiations Revealed: The MSF Experience
- The Practical Guide to Humanitarian Law
- Films about MSF
-
What we do
- Careers
-
Support us
- Donate online
- Mail in donations
-
Explore donation options
- Donate stocks and mutual funds
- Workplace giving & matching gifts
- Donor-advised funds (DAF) donations
-
Legacy giving
- Leave a gift in your will
- Name MSF as a charity beneficiary of IRA
- Give charitable gift annuities (charitable gifts)
- Charitable lead annuity trusts
- Join the Legacy Society
- Request a legacy (planned giving) brochure
- Thank you for requesting a Legacy brochure
- Bequest intention form
- Thank you and welcome to our Legacy Society
- Become a monthly donor
- Major Giving
- Join the Partner Program
- Make a donation to honor someone
- Foundation support
- Corporate support
- Qualified charitable distributions
- FAQ: Donating
- Donor services
-
Take action
- Donate
Learn more about us
How we use funds
